Evidence map›Paper›PMID 32576731›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2020

Quantifying the Dynamics of HIV Decline in Perinatally Infected Neonates on Antiretroviral Therapy.

Sinead E Morris, Luise Dziobek-Garrett, Renate Strehlau, Juliane Schröter, Stephanie Shiau, Anet J N Anelone, Maria Paximadis, Rob J de Boer, Elaine J Abrams, Caroline T Tiemessen and 3 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sinead E MorrisDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY.
Luise Dziobek-GarrettDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY.
Renate StrehlauDepartment of Paediatrics and Child Health, Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Juliane SchröterDepartment of Theoretical Biology and Bioinformatics, Utrecht University, Utrecht, Netherlands.
Stephanie ShiauGertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, NY.
Anet J N AneloneDepartment of Theoretical Biology and Bioinformatics, Utrecht University, Utrecht, Netherlands.
Maria PaximadisCentre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services, and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Rob J de BoerDepartment of Theoretical Biology and Bioinformatics, Utrecht University, Utrecht, Netherlands.
Elaine J AbramsDepartment of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY.
Caroline T TiemessenCentre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services, and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Louise KuhnGertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, NY.
Andrew J YatesDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY.
EPIICAL Consortium and the LEOPARD study team

Funding

Early neonatal treatment and immune quiescenceU01HD080441 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KUHN, LOUISE · 2014 to 2018
$5.1M
NICHD NIH HHS U01 HD080441
6 · The paper itself

Abstract

backgroundMathematical modeling has provided important insights into HIV infection dynamics in adults undergoing antiretroviral treatment (ART). However, much less is known about the corresponding dynamics in perinatally infected neonates initiating early ART.

settingFrom 2014 to 2017, HIV viral load (VL) was monitored in 122 perinatally infected infants identified at birth and initiating ART within a median of 2 days. Pretreatment infant and maternal covariates, including CD4 T cell counts and percentages, were also measured.

methodsFrom the initial cohort, 53 infants demonstrated consistent decline and suppressed VL below the detection threshold (20 copies mL) within 1 year. For 43 of these infants with sufficient VL data, we fit a mathematical model describing the loss of short-lived and long-lived infected cells during ART. We then estimated the lifespans of infected cells and the time to viral suppression, and tested for correlations with pretreatment covariates.

resultsMost parameters governing the kinetics of VL decline were consistent with those obtained previously from adults and other infants. However, our estimates of the lifespan of short-lived infected cells were longer than published values. This difference may reflect sparse sampling during the early stages of VL decline, when the loss of short-lived cells is most apparent. In addition, infants with higher pretreatment CD4 percentage or lower pretreatment VL trended toward more rapid viral suppression.

conclusionsHIV dynamics in perinatally infected neonates initiating early ART are broadly similar to those observed in other age groups. Accelerated viral suppression is also associated with higher CD4 percentage and lower VL.

Indexed as

Anti-HIV AgentsCD4 Lymphocyte CountFemaleHIV-1HIV InfectionsHumansInfant, NewbornInfant, Newborn, DiseasesInfectious Disease Transmission, VerticalKineticsMaleSouth AfricaAnti-HIV Agents

Identifiers

PMID32576731
PMCPMC8818299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.